Smith & Nephew SNATS (NYSE:SNN) Cut to “Buy” at Wall Street Zen

Wall Street Zen lowered shares of Smith & Nephew SNATS (NYSE:SNN) from a strong-buy rating to a buy rating in a research note published on Friday.

Several other research firms have also recently issued reports on SNN. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Smith & Nephew SNATS in a research report on Saturday, September 27th. Canaccord Genuity Group boosted their price target on Smith & Nephew SNATS from $28.00 to $36.00 and gave the stock a “hold” rating in a research note on Monday, August 18th. Seven research analysts have rated the stock with a Hold rating, According to MarketBeat.com, Smith & Nephew SNATS presently has a consensus rating of “Hold” and a consensus price target of $36.00.

Smith & Nephew SNATS Stock Down 0.3%

Shares of Smith & Nephew SNATS stock opened at $36.34 on Friday. The company has a 50-day simple moving average of $36.16 and a two-hundred day simple moving average of $31.23. The stock has a market capitalization of $15.83 billion, a PE ratio of 16.83, a price-to-earnings-growth ratio of 1.00 and a beta of 0.69. Smith & Nephew SNATS has a 52-week low of $23.69 and a 52-week high of $38.79. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.40 and a current ratio of 3.00.

Smith & Nephew SNATS Cuts Dividend

The company also recently declared a semi-annual dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 3rd will be paid a $0.285 dividend. This represents a dividend yield of 165.0%. The ex-dividend date is Friday, October 3rd. Smith & Nephew SNATS’s dividend payout ratio (DPR) is 26.39%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Bessemer Group Inc. boosted its position in Smith & Nephew SNATS by 3,471.4% in the first quarter. Bessemer Group Inc. now owns 1,750 shares of the medical equipment provider’s stock worth $49,000 after purchasing an additional 1,701 shares during the last quarter. Sequoia Financial Advisors LLC bought a new position in shares of Smith & Nephew SNATS in the 1st quarter worth approximately $211,000. GAMMA Investing LLC boosted its holdings in shares of Smith & Nephew SNATS by 22.4% in the first quarter. GAMMA Investing LLC now owns 3,641 shares of the medical equipment provider’s stock worth $103,000 after buying an additional 666 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in shares of Smith & Nephew SNATS by 37.7% in the first quarter. Oppenheimer Asset Management Inc. now owns 53,590 shares of the medical equipment provider’s stock worth $1,520,000 after buying an additional 14,677 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC bought a new stake in Smith & Nephew SNATS during the first quarter valued at approximately $335,000. Institutional investors own 25.64% of the company’s stock.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.